Innoviva (INVA) Invested Capital (2010 - 2026)
Innoviva's (INVA) quarterly Invested Capital came in at $191.9 million in Q2 2025, little changed on a QoQ basis from $192.2 million in Q1 2025.
Analysis
Innoviva (INVA) Invested Capital (2010 - 2026) Analysis & Trends
Innoviva (INVA) has 14 years of Invested Capital data on file, last reported at $191.9 million in Q2 2025.
- Quarterly Invested Capital changed N/A year-over-year to $191.9 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $191.9 million (down 66.69% YoY) and the FY2024 annual result came in at $192.0 million, changed N/A from the prior year.
- Invested Capital held at $191.9 million in Q2 2025, from $192.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $433.5 million in Q2 2021 to a low of $96.0 million in Q1 2022.
- A 4-year average of $201.9 million and a median of $191.9 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital changed 0.0% — and 2022, when it plunged 77.84%.
- Tracing INVA's Invested Capital over 4 years: stood at $433.5 million in 2021, then sank by 77.81% to $96.2 million in 2022, then surged by 99.63% to $192.0 million in 2024, then dropped by 0.07% to $191.9 million in 2025.
- The last three Invested Capital figures came in at $191.9 million (Q2 2025), $192.2 million (Q1 2025), and $192.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn | 1.49 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.60 Bn |
| Dec 31, 2025 | 1.43 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 1.10 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.11 Bn |
| Mar 31, 2024 | 1.15 Bn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.00 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.18 Bn |
| Jun 30, 2022 | 661.53 Mn |
| Mar 31, 2022 | 648.23 Mn |
| Dec 31, 2021 | 920.59 Mn |
| Sep 30, 2021 | 884.10 Mn |